Nuzenio

Molecular Therapeutics

Molecular Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 6 publisher sources 100/100 entity strength

Latest news

4D Molecular Therapeutics, Inc. (FDMT) insider sells 26,842 shares under plan - Stock TitanStock Titan · Wed, 05 Aug 2026 20:11:40 GMTKen Fisher's 4D Molecular Therapeutics Inc(FDMT) Holding History - GuruFocusGuruFocus · Wed, 05 Aug 2026 01:51:52 GMT4D Molecular Therapeutics (FDMT) Insider David Kirn Sells 12,415 Shares - GuruFocusGuruFocus · Wed, 05 Aug 2026 00:51:21 GMTDavid Kirn Sells 12,415 Shares of 4D Molecular Therapeutics (NASDAQ:FDMT) Stock - MarketBeatMarketBeat · Tue, 04 Aug 2026 21:31:25 GMT4D Molecular Therapeutics (FDMT) CEO sells 12,415 shares via 10b5-1 plan - Stock TitanStock Titan · Tue, 04 Aug 2026 20:46:01 GMTEnterprise value to revenue forward of 4D Molecular Therapeutics, Inc. – NASDAQ:FDMT - TradingViewTradingView · Tue, 04 Aug 2026 14:52:06 GMT4D Molecular Therapeutics CEO David Kirn disposes of 12,415 shares worth $124,987 - BitgetBitget · Tue, 04 Aug 2026 07:00:00 GMTFDMT (FDMT) investor David Kirn plans Rule 144 sale of 12,415 shares - Stock TitanStock Titan · Mon, 03 Aug 2026 21:30:55 GMT

Timeline

Wed, 05 Aug 2026 20:11:40 GMT4D Molecular Therapeutics, Inc. (FDMT) insider sells 26,842 shares under plan - Stock Titan
Wed, 05 Aug 2026 01:51:52 GMTKen Fisher's 4D Molecular Therapeutics Inc(FDMT) Holding History - GuruFocus
Wed, 05 Aug 2026 00:51:21 GMT4D Molecular Therapeutics (FDMT) Insider David Kirn Sells 12,415 Shares - GuruFocus
Tue, 04 Aug 2026 21:31:25 GMTDavid Kirn Sells 12,415 Shares of 4D Molecular Therapeutics (NASDAQ:FDMT) Stock - MarketBeat
Tue, 04 Aug 2026 20:46:01 GMT4D Molecular Therapeutics (FDMT) CEO sells 12,415 shares via 10b5-1 plan - Stock Titan
Tue, 04 Aug 2026 14:52:06 GMTEnterprise value to revenue forward of 4D Molecular Therapeutics, Inc. – NASDAQ:FDMT - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Molecular Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.